Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 8/2010

01-08-2010 | Erratum

Erratum to: Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma

Authors: Reinhold Ramoner, Andrea Rahm, Claudia E. Falkensammer, Nicolai Leonhartsberger, Martin Thurnher

Published in: Cancer Immunology, Immunotherapy | Issue 8/2010

Login to get access

Excerpt

Unfortunately the original version has been published without the Conflict of interest statement. Please find below the statement. …
Metadata
Title
Erratum to: Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma
Authors
Reinhold Ramoner
Andrea Rahm
Claudia E. Falkensammer
Nicolai Leonhartsberger
Martin Thurnher
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 8/2010
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-010-0863-8

Other articles of this Issue 8/2010

Cancer Immunology, Immunotherapy 8/2010 Go to the issue

Editorial

The tyranny of statistics in medicine: a critique of unthinking adherence to an arbitrary p value

Original Article

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

Original Article

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

Original Article

Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma

Original Article

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells

Original Article

Promoting effect of Antrodia camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits